Associated Papers
The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility.
Olszewska B et al.
Archives of Dermatological Research, 2021
The role of polymorphism of interleukin-2, -10, -13 and TNF-α genes in cutaneous T-cell lymphoma pathogenesis.
Nedoszytko B et al.
Postepy Dermatologii I Alergologii, 2016
Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA et al.
Cytokine, 2016
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
Markkula A et al.
Bmc Cancer, 2014
Three multiplex snapshot assays for SNP genotyping in candidate innate immune genes.
Esteves LM et al.
Bmc Research Notes, 2013
Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus.
Okada Y et al.
Human Molecular Genetics, 2011
Genotype x nutrient association of common polymorphisms in obesity-related genes with food preferences and time structure of energy intake.
Bienertová-Vasků J et al.
The British Journal of Nutrition, 2010
Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.
Chérel M et al.
Cytokine, 2009
Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results.
Vasků A et al.
International Journal of Colorectal Disease, 2009
Pharmacogenetic contribution of leptin gene polymorphism in cutaneous T-cell lymphoma.
Vasku V et al.
International Journal of Clinical and Experimental Pathology, 2009
Active and passive smoking, IL6, ESR1, and breast cancer risk.
Slattery ML et al.
Breast Cancer Research and Treatment, 2008
Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk.
Slattery ML et al.
Obesity (silver Spring, Md.), 2008
IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States.
Slattery ML et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2007
Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL).
Vasku JA et al.
Clinical Immunology (orlando, Fla.), 2004